ArticlePLoS neglected tropical diseases2025
Effectiveness of a reactive oral cholera vaccination during a cholera outbreak at the Douala New-Bell Central Prison in Cameroon.
Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundResearch on cholera vaccine effectiveness in prison populations is scarce, despite evidence of OCV benefits in general outbreak settings. During a major cholera outbreak in Douala's overcrowded central prison, Cameroon deployed the Euvichol oral cholera vaccine. This study assessed the vaccine's association with reduced cholera-related hospitalisation among inmates.
methodsA retrospective secondary data analysis was conducted in 2024 on inmates who were targeted for reactive vaccination during a cholera outbreak in 2022. A stratified sampling strategy based on gender and housing type was used to select eligible inmates. Vaccine status was ascertained from the prison's vaccination register. Our outcome variable of interest was cholera-related hospitalisation. Logistic regression was used to assess the likelihood of hospitalisation for severe cholera among vaccinated and unvaccinated inmates. Adjusted odds ratios (aOR) and associated 95% confidence intervals (CI) were obtained.
resultsA total of 323 inmates were included for analysis, of whom 110 (34.9%) were vaccinated. Cholera-related hospitalisations occurred in 147/213(57.3%) unvaccinated inmates compared to 45/110(41.7%) vaccinated inmates. For inmates who received one dose of OCV, hospitalisation was associated with an adjusted odds ratio of 0.39 (95% CI: 0.21-0.70; p = 0.002), while those who received two doses showed an adjusted OR of 0.37 (95% CI: 0.19-0.72; p = 0.003). In subgroup analyses, severe cholera was found to be associated with lower odds among female prisoners [aOR = 0.24, 95% CI: 0.08-0.70, p = 0.009] and among inmates in 'VIP' cells [aOR = 0.31, 95% CI: 0.11-0.84, p = 0.022].
conclusionVaccination was associated with a reduction in hospitalisation during the prison cholera outbreak, confirming its emergency value. However, OCV alone may not be sufficient if overcrowding and poor water, sanitation, and hygiene (WASH) conditions persist. Improved living standards, as seen in the female and VIP sections, must be extended to all inmates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.